Patent · US Active

Glycosidase inhibitors

US9879001B2 · kind B2 · utility

2Cited by

2References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Henry Yu · Wellesley, US
Lesley Liu-Bujalski · Bedford, US
Theresa L. Johnson · Salem, US

Key dates

Filing date	Mar 10, 2014
Grant date	Jan 30, 2018
Priority date	—
Expiry date	Mar 10, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/6893
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)wherein X1, X2, W, R1 to R5, L and m have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.